AGP Executive Report
Last update: 11 hours agoVaccine Trial: A Danish university and Guinea-Bissau officials have approved a controversial hepatitis B study involving 14,000 newborns, with half not receiving the vaccine at birth. The trial has drawn strong ethical criticism; reports say the CDC is setting aside $1.6 million to support it, though the study remains halted. Digital Identity: Guinea-Bissau is among seven ECOWAS countries to launch the bloc’s biometric identity card. ECOWAS aims for the card to be accepted across member-state borders by December 2026, easing regional travel and identity checks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.